Donate
Call the Lung HelpLine
Ask a Question
The following text field filters the results that follow as you type. Use Tab to access the results.
  1. Home
  2. Research & Reports
  3. About Our Research
  4. Meet the Researchers
  5. Kurt Prins, MD, PhD
Kurt Prins, MD, PhD

Kurt Prins, MD, PhD

University of Minnesota

Research Project:
Treating Right Heart Dysfunction to Improve Outcomes in PAH

Grant Awarded:

  • Innovation Award

Research Topics:

  • basic biologic mechanisms
  • combination therapies experimental therapeutics

Research Disease:

  • pulmonary vascular disease

We have shown small molecule inhibition of WNK1 signaling prevents metabolic derangements in the monocrotaline model of pulmonary arterial hypertension. In particular, we showed WNK1 inhibition prevented pathological increase in glucose uptake, activated AMP kinase signaling, which then manifested as augmented fatty acid metabolism. Importantly, these data suggest that WNK1 may be a target for RV dysfunction in pulmonary arterial hypertension, a currently untreatable consequence of pulmonary arterial hypertension.

Update: We have shown small molecule inhibition of WNK1 enhances RV metabolism and augments RV function in rodent pulmonary arterial hypertension.

Page last updated: April 18, 2024

Asthma Educator Institute
, | Jul 11, 2015
See All Events